The pan-European Stoxx 600 rose 0.2 per cent

Early research suggests Omicron may cause milder illnesses than previous variants

Just 13 per cent of people in Africa have received at least one dose of a Covid vaccine

Validity will be extended after booster shot without a time limit

Data shows no need for variant-specific vaccines, says Biden’s chief medical adviser

CSO figures reveal computer services and chemicals dominate State’s exports

Total global output will be more than 20 billion shots for the year

New coronavirus variant likely to be more transmissible but less severe, Fauci says

The variant has shown that wealthy states will be unable to vaccinate themselves to immunity while large areas remain unvaccinated

Actions also include drive to encourage vaccine boosters and expansion of at-home tests

President says US will work to accelerate development of any updated vaccines needed

How can businesses measure and improve their environmental performance?

Irish investment into the US is at an all-time high, with over 110,000 US citizens working for Irish companies

Almost 200,000 Covid tests carried out in past week amid surge in demand for service

Vaccination strategies and return-to-office policies vary greatly from country to country

Luxury goods groups Richemont and LVMH among standout performers

Boosters should have been rolled out as soon as they were approved – immunologist

Just 44% of central and eastern Europeans based in Ireland are vaccinated, says CSO

Regulator backs use of Spikevax shot for over 18s at least six months after second dose

Move possible through eight-year corporate power purchase agreement with Ørsted

New antibody treatment could help prevent Covid in those with poor vaccine response

Those vaccinated outside EU will also be able to apply, provided vaccine is authorised here

AstraZeneca, received by tens of millions in Europe, not approved by America’s regulator

What is company culture and does it really mean anything?

A series of studies found that one vaccine seems more protective over the long term

Johnson & Johnson study looks at impact of booster two months after original vaccination

Seen & heard: sharing construction costs; Janssen expansion; PwC backs Donohoe

Company completes dosing in first round of trial of treatment for coeliac disease

Albert Bourla believes it’s ‘feasible’ to inoculate at least 10% of people in every country

Rare condition has also been reported in people who were infected with Covid-19

A blanket third dose to protect Ireland against coronavirus looks increasingly likely

EU countries vote to reimpose restrictions on non-essential travel from US due to Covid surge

Data supports use of second shot among recipients of vaccine

Officials hope move will convince more unvaccinated Americans shot is safe and effective

CSO figures point to sharp increase in imports from North in wake of UK’s EU exit

A lack of alignment and clarity leaves many employees cynical and disengaged

Company has filed for regulatory authorisation for shot in India, Indonesia, Philippines

Bid for Translate Bio marks latest interest by large pharmaceutical firm in mRNA tech

Deal struck as EU worried about supplies and side effects of other vaccines

Pharma giant raises forecasts for full-year sales and profits after strong second quarter